On track: An exclusive licensing agreement will light up the world’s first DNA-based cannabis-tagging system.
FEBRUARY 14, 2019
By GREGORY ZELLER //
A partnership between a Stony Brook biotech and a Canadian pharmaceutical-solutions provider is growing like a weed.
Less than a year since introducing the world’s first DNA-based cannabis-tagging system and just five months since they upgraded the system to accommodate large-scale growers, Applied DNA Sciences and Canadian/Panamanian cohort TheraCann International Benchmark Corp. have inked an exclusive licensing deal.
